Abstract 4974: Pharmacogenomic interactions in glioblastoma cell line models
Rubén Ferrer-Luna(Boston Children's Hospital), Keith L. Ligon(Brigham and Women's Hospital), Mikael L. Rinne(Broad Institute), Patrick Y. Wen(Dana-Farber Cancer Institute), Paul A. Clemons(Broad Institute), Shakti Ramkissoon(Foundation Medicine (United States)), Jaime H. Cheah(Broad Institute), Stuart L. Schreiber(Broad Institute), Rameen Beroukhim(Broad Institute), Alice Meng(Tufts University), Karl Holmberg Olausson(Dana-Farber Cancer Institute), Yun Jee Kang(Dana-Farber Cancer Institute), Cécile L. Maire(Dana-Farber Cancer Institute), David A. Reardon(Dana-Farber Cancer Institute), Steven E. Schumacher(Broad Institute), Alykhan F. Shamji, Kristine Pellton(Dana-Farber Cancer Institute), Brenton R. Paolella(Broad Institute), Lori Ramkissoon(Dana-Farber Cancer Institute), Ahmed Idbaïh(Centre National de la Recherche Scientifique), Wenyu Song(Dana-Farber Cancer Institute), Sam Haidar(Broad Institute), Rebecca Lamothe(Dana-Farber Cancer Institute)
Cited by 0
Related Papers
Regulation of Ferroptotic Cancer Cell Death by GPX4
|Cell|2014|7.5k
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k